Company intelligence

Lyell Immunopharma

As of November 3, 2026, Lyell Immunopharma has raised at least $80M in equity across 1 sourced funding round.

Biotech

Lyell Immunopharma at a glance

As of
Equity raised
$80M[1]
Across 1 sourced roundDerived
  1. [1] Equity raised: Sum of the 1 sourced equity round in the funding history below (debt, tender offers and rumored rounds excluded), November 3, 2026

Is something wrong on this page?

Recent changes

  1. Nov 3, 2026Raised $80M Morningstar
  2. Nov 3, 2026Lyell Immunopharma Raises $80M, Targets 2027 BLA For Ronde-Cel Pulse story

Funding history

1 equity event · newest first · sources dated per row
DateRoundAmountValuationLead investorsSource
Nov 3, 2026Funding round$80M—
—
MorningstarPulse story

Equity only. “Equity raised” above sums the rounds with a dated, linked source; rumored rounds, tender offers and secondary sales are listed but not counted, and debt financing is listed separately.

Latest Pulse

  1. Lyell Immunopharma Raises $80M, Targets 2027 BLA For Ronde-CelLyell Immunopharma has agreed to an $80 million private placement of common stock to fund its CAR T-cell candidate ronde-cel toward a planned BLA submission expected in the second half of 2027.→

Coverage Timeline

newest first
  1. Nov 3, 2026FUNDINGLyell Immunopharma Raises $80M, Targets 2027 BLA For Ronde-Cel$80M Private Placement→

All Coverage

FUNDING
Lyell Immunopharma Raises $80M, Targets 2027 BLA For Ronde-Cel
FUNDING$80M Private Placement

Lyell Immunopharma Raises $80M, Targets 2027 BLA For Ronde-Cel

Lyell Immunopharma has agreed to an $80 million private placement of common stock to fund its CAR T-cell candidate ronde-cel toward a planned BLA submission expected in the second half of 2027.

DEEP DIVE

Related Companies

Same sector
Scribe TherapeuticsIambic TherapeuticsAttovia TherapeuticsApnimedEli LillyRetension Pharmaceuticals

Lyell Immunopharma FAQ

How much has Lyell Immunopharma raised?

Lyell Immunopharma has raised at least $80M in equity across 1 sourced funding round tracked by Value Add VC. The most recent was an $80M funding round in November 2026, reported by Morningstar. Debt financing, tender offers and secondary sales are not counted.

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data ·